1. Ritanserin antagonism of m-chlorophenylpiperazine effects in neuroleptic-free schizophrenics patients: support for serotonin-2 receptor modulation of schizophrenia symptoms;Abi-Saab;Psychopharmacology (Berlin),2002
2. Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei;Adams;International Journal of Neuropsychopharmacology,2005
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th revised ed. Washington, DC: American Psychiatric Press; 1994.
4. Different serotonin receptors mediate blood pressure, heart rate, plasma catecholamine and prolactin responses to m-chlorophenylpiperazine in conscious rats;Bagdy;Journal of Pharmacology and Experimental Therapeutics,1989
5. Prolactin and cortisol responses to MK-212, a serotonin agonist, in obsessive-compulsive disorder;Bastani;Archives of General Psychiatry,1990